|
BELVIQ is approved by the FDA and will be available only after DEA scheduling is effective. Investors click here for additional information.
|
|
|
The BELVIQ Phase 3 BLOOM trial was published in the New England Journal of Medicine.
|
|
|
Pipeline of novel and selective drug candidates.
|
|
|
Our vision is to be the recognized world leader in GPCR drug discovery and development.
|
|
|
|
|